Condition

Major Depression With Comorbid Anxiety Symptoms

ClinicalTrials.gov condition label

Clinical trials4

Recruiting3

Common interventions4

Lead sponsors shown3

Clinical trials

4 shown

EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECTNCT07748091 · 2026-01-01

RECRUITING

EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECTNCT07740694 · 2025-12-01

RECRUITING

EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical TrialNCT07041073 · 2025-05-19

RECRUITING

A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With AnxietyNCT00229645 · 2003-11-01

COMPLETED

Common interventions

Electroconvulsive TherapyDEVICE2Active swLORETA Z-score NeurofeedbackDEVICE1Quetiapine Fumarate (Seroquel®)DRUG1Yoked-sham swLORETA Z-score NeurofeedbackDEVICE1

Leading sponsors

Istanbul University - Cerrahpasa2Corporacion Parc Tauli1Dr Alexander McIntyre Inc.1

Trial status mix

RECRUITING3

COMPLETED1

Phase mix

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.